Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2025-10-16 Earnings Release
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
DocMorris accelerates sequential Rx growth and increases non-Rx revenue
Earnings Release Classification · 100% confidence The document is a press release titled 'DocMorris accelerates sequential Rx growth and increases non-Rx revenue' dated 16 October 2025. It provides a summary of financial performance for the first nine months of 2025, including revenue figures, growth percentages, and management commentary. It is an initial announcement of financial results rather than a full quarterly report or a transcript. According to the filing definitions, this is an Earnings Release (ER). 9M 2025
2025-10-16 English
DocMorris accelerates sequential Rx growth and increases non-Rx revenue
Earnings Release Classification · 100% confidence The document is a press release from DocMorris AG detailing their 9-month financial figures for 2025. It includes key highlights, revenue growth metrics, management changes, and an outlook for the remainder of the year. It is a standard earnings-related announcement (often referred to as a trading update or quarterly results release) that provides key highlights rather than the full, comprehensive financial report. According to the filing definitions, this fits the 'Earnings Release' (ER) category. 9M 2025
2025-10-16 English
DocMorris beschleunigt sequenzielles Rx-Wachstum und steigert Non-Rx-Umsätze
Earnings Release Classification · 100% confidence The document is a media release from DocMorris AG detailing their 9-month financial performance for 2025. It includes key highlights such as revenue growth, segment performance (Rx and Non-Rx), management changes, and future outlook. It is a standard earnings release (initial announcement of periodical results) rather than a full quarterly report or a report publication announcement, as it contains the actual financial data tables and management commentary within the text itself. 9M 2025
2025-10-16 German
DocMorris safe and certified online supply of medicines
Regulatory Filings Classification · 100% confidence The document is a corporate press release issued by DocMorris regarding the safety of online medicine supply and the risks of counterfeit drugs. It does not report financial results, board changes, or specific regulatory filings, but rather serves as a general corporate communication/announcement regarding company standards and public health awareness. As it does not fit into specific categories like earnings, dividends, or governance reports, it falls under the general regulatory/corporate announcement category.
2025-09-05 English
DocMorris increases Rx revenue by over 40 per cent in the first half of the year and continues to expand its health ecosystem
Earnings Release Classification · 100% confidence The document is an 'ad hoc announcement' regarding half-year financial results. It provides key financial highlights, revenue growth, and EBITDA figures for the first half of 2025. Crucially, it explicitly states that the full half-year report and presentation are available as a separate download on the company's website, and it includes details for an upcoming conference call. Following the 'Menu vs Meal' rule, this document serves as the initial announcement of the results rather than the full interim report itself, making it an Earnings Release (ER). H1 2025
2025-08-19 English
DocMorris increases Rx revenue by over 40 per cent in the first half of the year and continues to expand its health ecosystem
Earnings Release Classification · 100% confidence The document is an 'Ad hoc announcement' regarding 'Half Year Results' for DocMorris AG. It provides a summary of key financial highlights, revenue growth, and EBITDA performance for the first half of 2025. While it contains financial tables, it explicitly states that the full 'half-year report and presentation are available on the website as a download', identifying this document as the initial release of financial highlights rather than the full report itself. Therefore, it is classified as an Earnings Release (ER). H1 2025
2025-08-19 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.